Second line trastuzumab emtansine following horizontal dual blockade
A new study published in Oncotarget reports that despite relevant medical advancements, metastatic breast cancer remains an incurable disease.
Jun 4, 2020
0
1
A new study published in Oncotarget reports that despite relevant medical advancements, metastatic breast cancer remains an incurable disease.
Jun 4, 2020
0
1
The year's biggest meeting of cancer researchers was subjected to a coronavirus overhaul this year, but even in scaled-back form it forced investors to recalibrate their expectations for some closely watched medicines.
Jun 2, 2020
0
0
Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment, according to exploratory ...
May 22, 2020
0
3
As of Wednesday, there's an FDA-approved treatment option besides chemotherapy for people with triple-negative breast cancer that has spread to other parts of the body.
Apr 24, 2020
0
12
The protein peptidyl arginine deiminase 4 (PAD4), which enables some immune cells to trap bacteria, promoted breast cancer metastasis in mice when expressed in cancer cells, according to data published in Molecular Cancer ...
Mar 19, 2020
0
29
(HealthDay)—For patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC) treated with pertuzumab and/or trastuzumab emtansine (T-DM1), a body mass index (BMI) of ≥30 kg/m² ...
Feb 12, 2020
0
1
Working in close partnership with patients, scientists at the Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Count Me In have identified new causes of a rare cancer of blood vessel walls called angiosarcoma. ...
Feb 10, 2020
0
58
Metastasis, the spread of tumor cells to distant sites, is the major cause of death for people impacted by cancer. With no therapeutic cure available, it is clear that new treatments are needed urgently.
Jan 16, 2020
0
40
Researchers at the University of Maryland School of Medicine (UMSOM) developed a new nanoparticle drug formulation that targets a specific receptor on cancer cells, and appears to be more effective than a standard nanoparticle ...
Jan 15, 2020
0
305
Metastatic breast cancer patients who received an oral formulation of the chemotherapy drug paclitaxel had better response and survival and less neuropathy than patients who received intravenous paclitaxel, according to results ...
Dec 17, 2019
0
1